NCT06101264

Brief Summary

The purpose of this study is to assess the effect of virtual reality on subjective post-operative pain, total inpatient narcotic administration, and mobilization with physical therapy in pediatric patients who have undergone surgical correction for idiopathic scoliosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 16, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 26, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
4 months until next milestone

Results Posted

Study results publicly available

September 22, 2025

Completed
Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

1.4 years

First QC Date

October 16, 2023

Results QC Date

June 3, 2025

Last Update Submit

September 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Average Change in Subjective Pain Level Using a 10 Point Likert Scale

    This tool uses a 10-point scale that ranges from 0 (no pain) to 10 (worst possible pain). Pain will be assessed using this tool before and after every physical therapy session. The change in pain before and after each physical therapy session will be calculated and averaged across each patient.

    2 times daily postoperatively until hospital discharge (up to 60 days postoperatively)

Secondary Outcomes (2)

  • Total Amount of Administered Opioids During the Post-operative Period

    From post-operative day 1 until hospital discharge (up to 60 days postoperatively)

  • Average Number of Physical Therapy Sessions Prior to Receiving Clearance by Physical Therapy Staff

    Post-operative day 1 until clearance by physical staff (up to 60 days postoperatively)

Study Arms (2)

Virtual Reality

EXPERIMENTAL

Participants will receive a post-operative virtual reality intervention following corrective surgery for idiopathic scoliosis.

Device: Virtual Reality

Control

EXPERIMENTAL

Patients not receiving virtual reality intervention following corrective surgery for idiopathic scoliosis.

Device: Control

Interventions

ControlDEVICE

Control patients following spinal fusion for adolescent idiopathic scoliosis that receive no virtual reality sessions.

Control

Patients will undergo a 20 minute virtual reality session prior to each physical therapy session following spinal fusion for adolescent idiopathic scoliosis. Virtual reality sessions will continue until functionally cleared by physical therapy.

Virtual Reality

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • All pediatric patients (ages 13-18) at Connecticut Children's undergoing surgical correction for idiopathic scoliosis over a span of 12 months

You may not qualify if:

  • History of seizures
  • Cognitive developmental delay precluding participation in VR
  • Head or neck surgery that does not allow a head-mounted display to be worn safely
  • Chronic pain requiring the daily use of opioids for more than 2 weeks prior to the procedure
  • Non-English speakers
  • Side effects during screening
  • Patients with vagal nerve stimulators, cardiac pacemakers, and/or cochlear implants that may receive interference from the VR device

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Connecticut Children's Medical Center

Hartford, Connecticut, 06106, United States

Location

Limitations and Caveats

This study allocation of patients to the control group if they declined participation in the virtual reality sessions and is such not a true randomized controlled trial. Further, our prospective study has a small sample size as it is intended as a pilot study.

Results Point of Contact

Title
Prabhath Mannam
Organization
University of Connecticut School of Medicine

Study Officials

  • David Hersh, MD

    Connecticut Children's Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2023

First Posted

October 26, 2023

Study Start

January 1, 2024

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

September 22, 2025

Results First Posted

September 22, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations